UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.

Clinical pharmacokinetics

Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review.

Clinical pharmacokinetics

Rao PS, Modi N, Nguyen NT, Vu DH, Xie YL, Gandhi M, Gerona R, Metcalfe J, Heysell SK, Alffenaar JC

Volume of Distribution is Unaffected by Metabolic Drug-Drug Interactions.

Clinical pharmacokinetics

Sodhi JK, Huang CH, Benet LZ

Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain.

Clinical pharmacokinetics

Zheng Y, Chen X, Benet LZ

Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain.

Clinical pharmacokinetics

Zheng Y, Chen X, Benet LZ

Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Clinical pharmacokinetics

Christians U, Jacobsen W, Benet LZ, Lampen A

Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Clinical pharmacokinetics

Christians U, Jacobsen W, Benet LZ, Lampen A

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein.

Clinical pharmacokinetics

Zhang Y, Benet LZ

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein.

Clinical pharmacokinetics

Zhang Y, Benet LZ

Chiral bioequivalence: effect of absorption rate on racemic etodolac.

Clinical pharmacokinetics

Boni JR, Korth-Bradley JM, Richards LS, Chiang ST, Hicks DR, Benet LZ

Chiral bioequivalence: effect of absorption rate on racemic etodolac.

Clinical pharmacokinetics

Boni JR, Korth-Bradley JM, Richards LS, Chiang ST, Hicks DR, Benet LZ